Revvity, Inc. Announces Results of Annual Shareholder Meeting

Details

The elections for all ten director nominees received majority support, with the proposal to ratify Deloitte & Touche LLP as the independent auditor also passing. The non-binding advisory vote on executive compensation and the shareholder proposal to adopt a simple majority voting standard were both approved by the shareholders.

Items reported

About Revvity Inc.

Revvity Inc. is a global life sciences and diagnostics company that provides health science solutions, technologies, and services for research, development, and clinical testing. Revvity’s current business is organized around two main segments: Life Sciences, which supplies reagents, instruments, and software to support biopharma and academic research; and Diagnostics, which offers assay platforms, instruments, and software for reproductive health, immunodiagnostics, newborn screening, applied genomics, and infectious disease testing. The company also focuses on translational multi-omics, biomarker identification, imaging, screening, detection, and informatics, helping customers move biological data through connected laboratory workflows. Revvity serves pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations across global markets. Headquartered in Waltham, Massachusetts, Revvity plays an important role in enabling scientific discovery and supporting clinical decision-making across the healthcare and research ecosystem.